Royal Philips to distibute Corindus robot system designed to help clear obstructed arteries
Corindus Vascular Robotics of Natick said that the large Dutch conglomerate Royal Philips Electronics will help distribute its robot system designed for the treatment of patients with obstructed coronary arteries. Under the agreement, Philips will sell the system in the United States. The financial details of the exclusive distribution agreement were not disclosed. Recently approved by the Food and Drug Administration, the Corindus CorPath 200 is a robotic-assisted system for the minimally invasive treatment of obstructed coronary arteries.